Alec Barclay is Chief Operations Officer at T2 Biosystems, Inc. (TTOO). They have made 1 open-market trade across 1 company since 2019, most recently 2022-04-08.
CIK 0001734339
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $6K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TTOO | 181,944 | $24K |
Shares reported on the most recent Form 4, priced at the 2022-04-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TTOO | BUY | 2022-04-08 | 2022-04-11 | $0.50 | $6K | -21.1% | -61.1% | -72.2% |
| TTOO | SELL · 10b5-1 | 2021-03-17 | 2021-03-18 | $1.86 | $23K | -16.5% | -36.2% | -28.1% |
| TTOO | SELL · 10b5-1 | 2021-02-23 | 2021-02-23 | $2.06 | $15K | -29.4% | -25.9% | -51.5% |
| TTOO | SELL · 10b5-1 | 2020-02-24 | 2020-02-25 | $0.82 | $5K | -25.2% | -10.9% | +5.0% |
| TTOO | SELL · 10b5-1 | 2019-09-11 | 2019-09-13 | $2.92 | $12K | +0.0% | -9.7% | -59.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.